Glyphosate-cancer case appeal: Judge inclined to set aside $250 million of damages, order new trial

| | October 11, 2018
Unknown
Dwayne Johnson alleges Roundup exposure caused his cancer
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Bayer AG won a tentative ruling slashing the lion’s share of a $289 million verdict in the first trial over claims that Roundup weed killer causes cancer and a judge is considering a new trial on whether the company is at fault for an ex-school groundskeeper’s illness.

A San Francisco state judge indicated ahead of an oral hearing on the company’s challenge to the August verdict that she’s inclined to set aside $250 million in punitive damages against Monsanto, which Bayer acquired this year. The ruling could shift momentum in the company’s favor as it defends against thousands of U.S. lawsuits.

Superior Court Judge Suzanne Ramos Bolanos said that even if she doesn’t vacate the punishment damages, she “would grant a new trial on grounds of insufficiency of the evidence to justify the award for punitive damages.” She also questioned whether the evidence introduced at trial supports the jury’s conclusion that Bayer was liable for plaintiff Lee Johnson’s non-Hodgkin lymphoma based on his exposure to the key ingredient in Roundup, glyphosate.

Related article:  Pediatrician debunks claims that GMOs and chemicals used with them are bad for the environment

If the company can persuade the judge to erase or slash the nine-figure verdict — the first case to go to a jury among 8,700 people in the U.S. who blame the popular herbicide for their cancer — legal experts say some plaintiffs may be less eager to pursue their claims.

Read full, original article: Bayer Judge Favors Slashing Award in First Roundup Cancer Trial

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend